- Published at
- by gurufocus.com
positive
positive
Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong | ALBT Stock News
Avalon GloboCare (ALBT) secures a 20-year patent in Hong Kong for their CAR-T and CAR-NK cell technology. The patent targets CD19 and CD22 antigens to r